Abstract
This review is a brief but comprehensive overview on the multi-target profile of oleocanthal, an extra-virgin olive oil (EVOO) phenol corresponding to the (-)-decarboxymethylligstroside aglycone, speculating about its potential in the prevention and/or treatment of various diseases, such as neurodegeneration, inflammation and cancer.
Keywords: Olive oil, oleocanthal, biological targets, multi-pharmacological effect, cancer, inflammation, neurodegeneration.
Current Bioactive Compounds
Title:Multi-Target Profile of Oleocanthal, An Extra-Virgin Olive Oil Component
Volume: 12 Issue: 1
Author(s): Agostino Casapullo, Federica Del Gaudio, Angela Capolupo, Chiara Cassiano and Maria Chiara Monti
Affiliation:
Keywords: Olive oil, oleocanthal, biological targets, multi-pharmacological effect, cancer, inflammation, neurodegeneration.
Abstract: This review is a brief but comprehensive overview on the multi-target profile of oleocanthal, an extra-virgin olive oil (EVOO) phenol corresponding to the (-)-decarboxymethylligstroside aglycone, speculating about its potential in the prevention and/or treatment of various diseases, such as neurodegeneration, inflammation and cancer.
Export Options
About this article
Cite this article as:
Casapullo Agostino, Del Gaudio Federica, Capolupo Angela, Cassiano Chiara and Monti Chiara Maria, Multi-Target Profile of Oleocanthal, An Extra-Virgin Olive Oil Component, Current Bioactive Compounds 2016; 12 (1) . https://dx.doi.org/10.2174/1573407212666151231184806
DOI https://dx.doi.org/10.2174/1573407212666151231184806 |
Print ISSN 1573-4072 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6646 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Quinoxalinone as a Privileged Platform in Drug Development
Mini-Reviews in Medicinal Chemistry Lipoprotein (a) Evolution: Possible Benefits and Harm. Genetic and Non-Genetic Factors Influencing its Plasma Levels
Current Medicinal Chemistry Use of Medication in Coronary Imaging by CT
Current Medical Imaging Bioactive Polyphenols from Healthy Diets and Forest Biomass
Current Nutrition & Food Science Incretin-Based Therapy of Type 2 Diabetes Mellitus
Current Protein & Peptide Science The Role of Platelets in Athero-Thrombotic Events
Current Pharmaceutical Design Massively Parallel Screening of the Receptorome
Combinatorial Chemistry & High Throughput Screening Searching for Phytoinsulins as Cardiovascular Protector in Metabolic Syndrome
Current Pharmaceutical Design LncRNA as a Therapeutic Target for Angiogenesis
Current Topics in Medicinal Chemistry Transcatheter Aortic Valve Implantation Infective Endocarditis: Current Data and Implications on Prophylaxis and Management
Current Pharmaceutical Design AAV Vectorization of DSB-mediated Gene Editing Technologies
Current Gene Therapy Patent Selections:
Recent Patents on Medical Imaging A Pilot Study on Prostate Cancer Risk and Pro-Inflammatory Genotypes: Pathophysiology and Therapeutic Implications
Current Pharmaceutical Design Resveratrol and Ischemic Preconditioning in the Brain
Current Medicinal Chemistry Dexmedetomidine Use in General Anaesthesia
Current Drug Targets Health Outcomes Associated with Hormone Therapy in Australian Women
Current Drug Safety Synthesis, Characterizations and Microbial Studies of Novel Mannich Products Using Multicomponent Reactions
Current Bioactive Compounds Varicella-Zoster Virus Infections During Pregnancy: Epidemiology, Clinical Symptoms, Diagnosis, Prevention and Therapy
Current Pediatric Reviews New Insights into the Mechanism of Action of Aspirin in the Prevention of Colorectal Neoplasia
Current Pharmaceutical Design Role of Opioid Antagonists in the Treatment of Women with Glucoregulation Abnormalities
Current Pharmaceutical Design